Indo-National acquires 54.79% stake in Medcuore Medical Solutions

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

NIPPOBATRY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹404.00

prior close

₹407.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.1%+0.2% vs market

Household Products peers, median of 8sector-0.2%-1.8% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 1.8 pts less than its Household Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0-2.1+0.2-0.2-1.8

Next day

-5.9-2.0-3.9-0.8-5.1

-5.9-0.0-5.9+0.0-6.0

-8.2-0.4-7.8-2.0-6.2

-7.2+1.4-8.6-0.4-6.8

-6.5+0.1-6.6-3.1-3.4

-5.7+5.2-10.9-1.9-3.7

15d

-14.3+3.7-18.0+4.6-19.0

-16.6+3.5-20.1+2.1-18.7

-31.5-9.4-22.1-13.8-17.6

-20.5+9.0-29.5+2.0-22.5

UpDownMarket · Nifty Microcap 250Sector · Household Products peers, median of 8Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo-National has invested Rs 6.94 crore in Medcuore Medical Solutions Private Ltd (MMSPL), acquiring 54.79% stake (7,551 shares at Rs 9,187 each) and making it a subsidiary. MMSPL makes air monitoring systems and air purifiers, with FY25 turnover of Rs 35.4 lakh. This is a cash deal and not a related party transaction. Indo-National, known for Nippo batteries, is diversifying into the clean air solutions segment.

Likely market impact

Diversifies into air purification space. Target is small (Rs 35 lakh revenue), so limited near-term impact on financials or stock price.